Gilpin Wealth Management’s Mesa Laboratories MLAB Stock Holding History

Gilpin Wealth Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$130	Hold	1	–	–	﹤0.01%	1249
2026 Q2	$100	Hold	1	–	–	﹤0.01%	1019
2026 Q1	$89	Hold	1	–	–	﹤0.01%	959
2025 Q4	$79	Buy	+1	New	+$76	﹤0.01%	873

Other funds holding MLAB

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Gilpin Wealth Management's MLAB Position: Q3 2026 in Review

Gilpin Wealth Management held its Mesa Laboratories (MLAB) position steady in Q3 2026 at 1 share worth $130. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Gilpin Wealth Management first reported a position in MLAB in Q4 2025 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

Gilpin Wealth Management held 1 share of Mesa Laboratories worth $130 as of Q3 2026.
Gilpin Wealth Management left its Mesa Laboratories share count unchanged in Q3 2026.
Mesa Laboratories made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1249 holding.
Gilpin Wealth Management first reported a position in Mesa Laboratories in Q4 2025 and has held it in 4 quarters since.
4 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.